Kura Oncology (KURA) Insider Trading & Ownership $9.01 +0.04 (+0.45%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Kura Oncology (NASDAQ:KURA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$2.01 M Get KURA Insider Trade Alerts Want to know when executives and insiders are buying or selling Kura Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KURA Insider Buying and Selling by Quarter Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Kura Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/18/2024Kathleen FordCOOSell526$16.03$8,431.78 5/20/2024Teresa Brophy BairInsiderSell2,615$22.15$57,922.25 1/29/2024Kathleen FordCOOSell1,496$17.80$26,628.80 1/29/2024Teresa Brophy BairInsiderSell2,053$17.80$36,543.40 1/29/2024Thomas James DoyleSVPSell2,318$17.80$41,260.40 1/24/2024Troy Edward WilsonCEOSell91,052$20.23$1,841,981.96 (Data available from 1/1/2013 forward) KURA Insider Trading Activity - Frequently Asked Questions Who is on Kura Oncology's Insider Roster? The list of insiders at Kura Oncology includes Kathleen Ford, Kirsten Flowers, Teresa Brophy Bair, Thomas James Doyle, Thomas Malley, and Troy Edward Wilson. Learn more on insiders at KURA. What percentage of Kura Oncology stock is owned by insiders? 5.50% of Kura Oncology stock is owned by insiders. Learn more on KURA's insider holdings. Which Kura Oncology insiders have been buying company stock? The following insider purchased KURA shares in the last 24 months: Thomas Malley ($575,000.00). How much insider buying is happening at Kura Oncology? Insiders have purchased a total of 50,000 KURA shares in the last 24 months for a total of $575,000.00 bought. Which Kura Oncology insiders have been selling company stock? The following insiders have sold KURA shares in the last 24 months: Kathleen Ford ($60,354.27), Kirsten Flowers ($26,474.34), Teresa Brophy Bair ($94,465.65), Thomas James Doyle ($62,762.12), and Troy Edward Wilson ($1,841,981.96). How much insider selling is happening at Kura Oncology? Insiders have sold a total of 105,335 Kura Oncology shares in the last 24 months for a total of $2,086,038.34 sold. Kura Oncology Key ExecutivesDr. Troy Edward Wilson J.D. (Age 55)Ph.D., Chairman, CEO & President Compensation: $1.22MMs. Kathleen Ford (Age 77)Chief Operating Officer Compensation: $824.95k1 recent tradesMs. Teresa Brophy Bair Esq. (Age 53)J.D., Chief Legal Officer & Corporate Secretary Compensation: $705.38kDr. Stephen Dale M.D. (Age 52)Chief Medical Officer Compensation: $855.3kMr. Thomas Doyle (Age 53)Senior Vice President of Finance & Accounting Mr. Pete De SpainExecutive Vice President of Investor Relations & Corporate CommunicationsDr. Roger Bakale Ph.D.Senior Vice President of Manufacturing & Supply ChainMs. Maureen Clancy M.B.A.VP and Global Head of Program Leadership & Project ManagementDr. Mollie Leoni M.D.Executive Vice President of Clinical DevelopmentMr. Brian T. Powl M.B.A. (Age 50)M.S., Chief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies Merus Insider Transactions ACADIA Pharmaceuticals Insider Transactions Twist Bioscience Insider Transactions Vericel Insider Transactions SpringWorks Therapeutics Insider Transactions Zai Lab Insider Transactions Kymera Therapeutics Insider Transactions Gemini Therapeutics Insider Transactions Vera Therapeutics Insider Transactions Bausch Health Companies Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:KURA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.